Skip to main content
Premium Trial:

Request an Annual Quote

Centogene CentoXome Gold, CentoXome Platinum

Centogene has released two clinical exome sequencing patient-parent trio tests, CentoXome Gold and CentoXome Platinum. The tests include Sanger confirmation and a medical report, using the company's proprietary CentoMD variant database, and promise reportable variants in more than 60 percent of cases. CentoXome Gold, which covers 95 percent of targets with greater than 10-fold coverage, has a turnaround time of 45 to 60 days and a price of €1,980 ($2,180). CentoXome Platinum covers 95 percent of targets with greater than 20-fold coverage. The test, which is aimed at urgent cases, including prenatal testing, has a turnaround time of less than 15 days and a price of €3,975.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.